Innovation in MedTech and Diagnostics Conference London 2025

Innovation in MedTech and Diagnostics Conference London 2025: Connecting the Ecosystem is set to explore the future of diagnostics and healthcare delivery in the UK, spotlighting the nation’s strengths in NHS clinical excellence, innovative R&D, and advanced wound care. 

The agenda features keynote presentations on the next decade of MedTech, with deep dives into decentralisation, AI in pathology, multi‑omics for chronic diseases and sustainable drug delivery.

This dynamic two‑day event will unite 150 experts from academia, healthcare, biotech, pharma and government, offering a mix of invited talks, interactive panels and networking opportunities. Join us to learn from industry pioneers, share ideas and forge new connections within this rapidly advancing field.

Day 1 Agenda

(DAY 1) Tuesday 21st October 2025 agenda: Innovating the Future of HealthTech

9:00 Registration and breakfast.

9:30 Keynote address: The next ten years for healthtech — visionary insights into the future trajectory of health technologies. 

10:00 Second Speaker: Where the UK can play in the future of healthtech? Opportunities and strategies for the UK to lead in global HealthTech innovation - Alex McLaughlin, Deputy Director at Office for Life Sciences 

10:30 Refreshment and networking break

Theme 1: Sensor-enabled management of cardiovascular disease

11:00 Quickfire session 1: Clinical or market need. Exploring the demands and opportunities in cardiovascular health management. 

11:20 Quickfire session 2: Technologies or solutions: A US success story — Highlighting innovative sensor-enabled solutions making waves in the US market. 

11:40 Panel discussion: A deep dive into the theme with four expert panelists, including quickfire session speakers. 

12:30️ Lunch

Theme 2: Continuous monitoring and treatment for managing wound care

13:45 Quickfire Session 1: Clinical or market need.

14:05 Quickfire Session 2: Technologies or solutions: a US success story. 

14:25 Panel discussion: Industry leaders discuss advancements in wound care monitoring and treatment. 

15:35 Refreshment and networking break

Theme 3: Reducing, replacing, and recycling in drug delivery

15:50 Quickfire Session 1: Clinical or market need — Bal Johal, Director of R&D at Owen Mumford.

16:10 Quickfire Session 2: Technologies or solutions: a US success story — Greg Anderson, Managing Director at Pharmacentric Solutions

16:30 Panel discussion: Four speakers delve into sustainability and innovation in drug delivery systems. 

17:00 Wrap-up: Consolidating the day’s insights and looking ahead at actionable steps. 

17:30 Day 1 Close.

Day 2 Agenda

(DAY 2) Wednesday 22nd October 2025 agenda: Exploring the Future of Diagnostics

9:00 Registration and breakfast

9:30 Keynote address: The next ten years for diagnostics — Insights into emerging trends and innovations set to shape the diagnostics landscape over the next decade.

10:00 Unlocking opportunities: the UK’s role in shaping the future of diagnostics

10:30 Refreshment and networking break

Theme 1: Decentralisation of diagnostics for infectious disease and anti-microbial resistance (AMR)

11:00 Quickfire session 1: Clinical or market need — A rapid dive into emerging clinical demands and the barriers to overcome to realise the market opportunities they present.

11:20 Quickfire session 2: Technologies or solutions: a US success story — Showcasing innovative diagnostics solutions with real-world impact.

11:40 Panel discussion: Four industry experts discuss decentralisation strategies.

12:30 Lunch

Theme 2: The potential for AI in pathology — Resolving complexity and addressing the resource gap

13:45 Quickfire session 1: Clinical or market need.

14:05 Quickfire session 2: Technologies or Solutions: A US success story — Donal O’Shea, Chief Executive at Deciphex.

14:45 Panel discussion: Four industry leaders share insights on how AI is transforming pathology.

15:35 Refreshment and networking break

Theme 3: The role of multi-omics in managing chronic diseases — From cancer to neurodegenerative diseases

15:50 Quickfire Session 1: Clinical or market need — Nigel Jamieson, Clinical Senior Lecturer, Institute of Cancer Sciences and Honorary HPB surgeon at Glasgow Royal Infirmary.

16:10 Quickfire Session 2: Technologies or solutions: a US success story - Joseph Beecham, Chief Scientific Officer at Bruker Spatial.

16:30 Panel Discussion: Experts discuss how multi-omics is reshaping chronic disease management.

17:00: Panel discussion: Recap key takeaways and discuss actionable insights from the day.

17:30: End of Conference

Sponsorship Opportunities

There are a number of sponsorship opportunities on offer at the conference and you can find out more in the button below